Boston Scientific Corporation announced preliminary, unaudited financial results for the second quarter. According to the company, preliminary net sales for the second quarter were U.S. $852 million, as compared to $708 million for the second quarter of 2002, an increase of 20 percent. Excluding the favorable impact of foreign currency fluctuations, net sales were reported at $813 million, an increase of 15 percent. Excluding net special charges, the company currently estimates earnings per share (diluted) for the second quarter of 2003 of between $0.29 and $0.30, as compared to $0.23 per share for the second quarter of 2002, an increase of between 26 and 30 percent. The preliminary estimated net special charges for the quarter of $11 million (after-tax), or approximately $0.03 per share, include purchased research and development related to acquisitions, the company said.
to Daily News